“…To date, many gene carrier peptides have been developed and extensively tested in mammalian cells to achieve efficient nonviral gene therapy. , More recently, gene carrier peptides have been explored in plant cells and shown to deliver exogenous genes across the dual barrier consisting of the cell wall and plasma membrane. − The ability to delivery exogenous genes into plants can offer opportunities for enhancing crop yields and producing valuable pharmaceuticals or biofuels. − The existing plant gene delivery methods, such as the Agrobacterium method and biolistic-mediated delivery, are currently widely used but limited in terms of the sizes and types of deliverable DNA cargo, applicable plant types, and target organelles. , In contrast, peptide-mediated gene delivery has the potential to overcome these limitations. Polycation peptides are capable of condensing various sizes and types of DNA and forming peptide/DNA ionic complexes with tolerance toward nuclease-mediated degradation, − while cell-penetrating peptides (CPPs) have been shown to permeate the plasma membrane in a wide range of plant species and tissues. ,− To exploit these useful peptide properties, we designed gene carrier peptides obtained via the fusion of a polycation peptide to a CPP and found that the resulting carrier peptides successfully delivered plasmid and double-stranded DNA into plant cell nuclei. ,, Additionally, the carrier peptides composed of a polycation peptide and an organelle-targeting peptide achieved selective gene delivery to mitochondria and chloroplasts in several plant species ,, due to the high selectivity of the targeting peptides against these organelles …”